Comparison of the effect of the booster dose of COVID-19 vaccination, with BNT162b2, after two doses of ChAdOx-1 and its response especially comparing among KTR with different immunosuppressive regimen
Latest Information Update: 03 Aug 2022
At a glance
- Drugs AZD 1222 (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
- 03 Aug 2022 New trial record
- 08 Jun 2022 Results presented at the 2022 American Transplant Congress